Jeff Hsu
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- RNA Research and Splicing
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 5
- Oncology 6
- Pancreatic and Hepatic Oncology Research 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Matthias Groß (2 shared papers)A. Robert MacLeod (4 shared papers)Alexey S. Revenko (2 shared papers)Sven Diederichs (2 shared papers)Moritz F. Eissmann (2 shared papers)Monika Hämmerle (2 shared papers)Tony Gutschner (2 shared papers)Youngsoo Kim (4 shared papers)
- Journals
- Cancer Research (7 papers)Molecular Cancer Therapeutics (2 papers)European Journal of Cancer (2 papers)Journal of the American College of Cardiology (1 paper)Blood (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Jeff Hsu
21 papers receiving 1.7k citations
Jeff Hsu's Hit Papers
Peers
Comparison fields: 5 of 81
- Cancer Research 1.2k
- Molecular Biology 1.2k
- Pathology and Forensic Medicine 112
- Nephrology 41
- Endocrinology 26
Countries citing papers authored by Jeff Hsu
This map shows the geographic impact of Jeff Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Hsu more than expected).
Fields of papers citing papers by Jeff Hsu
This network shows the impact of papers produced by Jeff Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Hsu. The network helps show where Jeff Hsu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeff Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells Hit paper breakdown → | 2012 | 1369 |
| 2 | 2002 | 90 | |
| 3 | 2006 | 61 | |
| 4 | 2002 | 52 | |
| 5 | 2015 | 40 | |
| 6 | The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma. | 2016 | 38 |
| 7 | 2015 | 26 | |
| 8 | 2011 | 17 | |
| 9 | 2022 | 13 | |
| 10 | 2005 | 10 | |
| 11 | 2016 | 10 | |
| 12 | 2020 | 9 | |
| 13 | 1995 | 4 | |
| 14 | 2025 | 3 | |
| 15 | 2013 | 2 | |
| 16 | 2016 | 1 | |
| 17 | 2016 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2014 | 1 | |
| 20 | 2012 | 1 |
About Jeff Hsu
Jeff Hsu is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 23 papers that have together received 1.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Phagocytosis and Immune Regulation (3 papers), Cancer Genomics and Diagnostics (2 papers), Galectins and Cancer Biology (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.2k citations), Pathology and Forensic Medicine (112 citations), Nephrology (41 citations) and Endocrinology (26 citations). Jeff Hsu has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Matthias Groß, A. Robert MacLeod, Alexey S. Revenko, Sven Diederichs, Moritz F. Eissmann, Monika Hämmerle, Tony Gutschner, Youngsoo Kim, Gene Hung and Marion Stentrup. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, European Journal of Cancer, Journal of the American College of Cardiology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.